IN SOLIDARITY

JUNE 8, 2020

Partners, friends and colleagues,

For centuries, Black communities in the United States have faced systemic racism, inequality and violence. Because silence fosters an environment where these injustices flourish, I am sharing this statement on behalf of the entire FHI Clinical team.

As an organization, FHI Clinical stands in solidarity with the brave individuals across the U.S. who are demanding change, and we stand with those working to advance equity and justice in all of the communities where we work around the globe. Because while the world watches the devastating impacts of racism ripple across the U.S., we must also acknowledge that racism is a global issue affecting people and communities everywhere.

FHI Clinical’s vision is to realize “a world where advances in vaccines and medicines help all people live longer, healthier lives.” We are committed to advancing the health of all people, and we honor this commitment by working in non-traditional research settings around the world to support the development of treatments for diseases from HIV and Ebola to malaria and Zika, diseases that disproportionally impact marginalized and underserved communities.

Today, we commit to being better and doing more. We will continue consulting and partnering with the communities where we work, and we will redouble our efforts to ensure that their voices inform and shape the way we do our work. We will reexamine our internal structures and evolve our practices to root out imbalances and inequality and ensure that everyone is represented, included and empowered.

We stand in solidarity with those who seek justice and the end of systemic racism, and we commit to ensuring that FHI Clinical continues to be a force for good in the world. 

Sincerely,

Ted FitzGerald
CEO and President, FHI Clinical

news archive

Five members added to the FHI Clinical Scientific Advisory Expert team

June 25, 2020
Several months ago, FHI Clinical began recruiting scientific and technological experts to join our newly formed panel of Scientific Advisory Experts, which was created to promote best practices, build alliances and spur innovation in the clinical trials research field. Today, we are pleased to announce that we have appointed five new members.

Read More »

Triangle Business Journal: Going Virtual

June 12, 2020
Claudia Christian, Senior VP, Clinical Operations, recently spoke with Seth Gulledge, writer for the Research Triangle Park, North Carolina-based Triangle Business Journal, about how the COVID-19 pandemic has disrupted the traditional model for clinical trials. This has prompted CROs around the Triangle to rapidly integrate virtual trial models to speed up clinical research and push COVID-19 vaccines and therapies to market.

Read More »

IN SOLIDARITY

June 8, 2020
Today, we commit to being better and doing more. We will continue consulting and partnering with the communities where we work, and we will redouble our efforts to ensure that their voices inform and shape the way we do our work. We will reexamine our internal structures and evolve our practices to root out imbalances and inequality and ensure that everyone is represented, included and empowered.

Read More »

Share this post

Share on linkedin
Share on twitter
Share on facebook